Home Case Index All Cases Central Excise Central Excise + AT Central Excise - 2017 (4) TMI AT This
Forgot password New User/ Regiser ⇒ Register to get Live Demo
2017 (4) TMI 211 - CESTAT NEW DELHITaxability - bulk drug 4 Hydroxy 7 Chloroqununoline - It is the case of the Revenue that 4 Hydroxy 7 Chloroqununoline emerging as intermediate product has distinct identity and marketability and since the final product is exempt, this intermediate product should suffer duty in the absence of any exemption - N/N. 6/2003-C.E. - Held that: - during the material time the subject goods which are admittedly used captively by the Respondent were covered for exemption under the above-mentioned Notification - As such we find the Respondent non-liability on Central Excise duty as held by the impugned order is correct - appeal dismissed - decided against Revenue.
|